Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

PSAM Questions Corporate Governance At Vivendi


News provided by

P. Schoenfeld Asset Management LP

30 Mar, 2015, 06:30 GMT

Share this article

Share toX

Share this article

Share toX

-- Sends Letter to Company Board 

-- Supports PhiTrust's "Florange Law" Resolution 

-- Again Clarifies Misrepresentations Made by Vivendi   

NEW YORK, March 30, 2015 /PRNewswire/ -- P. Schoenfeld Asset Management LP ("PSAM"), a shareholder since July 2012, today announced that it has sent a letter to the Board of Vivendi (EPA: VIV) (the "Company") containing questions concerning corporate governance at Vivendi as well as seeking clarification of recent actions taken by Vivendi Board Chairman Vincent Bollore.  A copy of the letter is available at www.valuecreationatviv.com.

PSAM believes all shareholders deserve prompt answers from Vivendi to the questions posed and should be informed about the issues referred to below:

1.         By not distributing adequate cash to shareholders and providing vague guidance about Vivendi's acquisition plans, Mr. Bollore and Vivendi's Management Board are asking investors to have blind faith in their plan for the company's future.  However, Mr. Bollore clearly does not have a detailed strategic plan for Vivendi (including with respect to capital allocation) since the Bollore Group recently purchased millions of Vivendi's shares in the market; knowledge of any such plan would be sensitive market information and would have restricted Mr. Bollore from acquiring shares. In the absence of a capital allocation strategy for Vivendi, the significant excess available cash should be distributed to the shareholders, as requested in the two resolutions submitted by PSAM to the Board on March 23rd.

2.         The Bollore Group very recently doubled its stake in Vivendi to approximately 10% as of March 26, 2015, thus benefiting from Vivendi's undervaluation and the absence of a detailed capital allocation plan.  PSAM is concerned that such opportunistic purchases by Bollore Group cede de facto control of Vivendi to Bollore Group (or Mr. Bollore) without having to pay the silent and disenfranchised majority investors a control premium for their shares.  The failure to utilize Vivendi's buyback program facilitates this situation as it provides Mr. Bollore control over Vivendi's core assets and cash resources at a low valuation as passive shareholders are forced to merely observe.

3.         As of June 4, 2014, Vivendi was authorized by shareholders to buy back shares at a maximum price of €24.00 per share.  On October 20, 2014 and February 27, 2015, the Management Board and the Supervisory Board respectively decided to lower the maximum price to €20.00 per share without explanation.  Shareholders should be told why the buy back price was lowered from €24.00 to €20.00.

4.         In late 2012, 2013 and 2015, Bollore Group engaged in multiple financing transactions totaling approximately €1.4 billion involving Vivendi's stock with very limited public disclosure.  We believe that members of the Supervisory Board should be provided with detailed terms and conditions of these transactions.  In addition, the Supervisory Board should confirm to shareholders that such transactions do not hedge the Bollore Group's economic exposure to Vivendi shares that the Bollore Group expects to vote at the annual general meeting.

5.         The implementation of double voting rights supported by the Boards under the "Florange Law" would allow Mr. Bollore to exert even more influence over Vivendi, leveraging his ownership into de facto control.  In order to discourage additional behavior that PSAM believes is detrimental to Vivendi shareholders, PSAM strongly supports and will vote in favor of PhiTrust's resolution to prevent double voting under the "Florange Law" from taking effect.

PSAM also addressed misrepresentations made by Vivendi regarding PSAM's resolutions and would like to stress the following:

  1. Contrary to Vivendi's allegations, there is no firm commitment by the Company to pay more than a single one-euro dividend after 2015.  Further dividend announcements are purely speculative "objectives."  Vivendi's price cap on its share buyback plan demonstrates that there is no willingness to implement it.  The buyback plan is merely an authorization, not an obligation.  As a result, there is only a one euro obligation under the Board's plan for the foreseeable future vs. a €6.66 September distribution under our two resolutions.
  2. Based on publicly available information, Vivendi has sufficient distributable profit and premium to implement PSAM's proposed resolutions (from a legal and accounting perspective).
  3. PSAM has taken into consideration Vivendi's cash constraints in proposing in its resolution that a dividend of €6.66 per share be paid on September 3rd (a date when proceeds from disposals should have been received).
  4. Distributing unallocated cash reserve cannot constitute an act of mismanagement; to the contrary, the decision of the Management Board to retain huge excess cash that is not allocated is questionable from a management perspective and has led to underperformance in the equity markets.
  5. With €5 billon excess cash post PSAM's proposed distribution and approximately €4 billion of marketable securities, Vivendi will still have the capacity to significantly expand its scope of operation and the company could retain all the financial flexibility it requires.
  6. PSAM has never called for the dismantling of Vivendi.  An IPO, partial spin or full spin of UMG to all shareholders are all suggestions for unlocking the value of an asset that PSAM believes is misunderstood by the market. 

In closing, PSAM urges Vivendi to provide answers to these questions and address these issues well in advance of the shareholder meeting so investors can make better educated decisions on the proposals before them.    

About PSAM
PSAM was founded by Peter M. Schoenfeld.  PSAM has been providing investment advisory services since 1997, with offices in New York and London.  PSAM has approximately $3.4 billion in assets under management and invests in both equity and credit securities in global event driven opportunities. 

Additional Information
This press release is for informational purposes only and is not intended to constitute, and should not be construed as, an offer to sell, a solicitation of any offer to buy, an offer to purchase or a solicitation of consents with regard to any securities of Vivendi (the "Company", and such securities, the "Securities").

This release may contain forward-looking statements.  Such statements can be identified by the use of forward-looking terminology such as "believes," "expects," "intends," "may," "estimates," "will," "should," "plans" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy.  These forward-looking statements involve a number of risks and uncertainties that could cause actual results to differ materially from the suggested by the forward-looking statements.  The information provided in this press release is derived from PSAM's analysis and subjective views on the Company and its Securities.  Other persons, including the Company, may have different analysis and views on the information provided herein.

No reliance is accepted on this press release and PSAM disclaims any liability in relation to this press release.  Investors shall only rely on their own assessment prior to taking any decision in relation to the Company and/or the Securities.  PSAM do not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For Investor Inquiries:
MacKenzie Partners, Inc.
Dan Burch/Bob Marese
+1-212-929-5500 / +44 20 3026 2807
dburch@mackenziepartners.com / bmarese@mackenziepartners.com

For Media Inquiries:
Image 7
Anne- France Malrieu
Ph : + 33 1 53 70 74 66
C : + 33 6 89 8 761 18
afmalrieu@image7.fr

Estelle Guillot-Tantay
Ph : + 33 1 53 70 74 93
C : + 33 6 87 60 49 58
egt@image7.fr

ASC Advisors
Steve Bruce/Taylor Ingraham
+1 (203) 992-1230
sbruce@ascadvisors.com / tingraham@ascadvisors.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.